Weiss Multi-Strategy Advisers LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$8,743,000
+12.2%
60,000
-8.7%
0.26%
+46.1%
Q1 2022$7,793,000
-22.2%
65,725
-9.5%
0.18%
-20.4%
Q4 2021$10,011,000
-6.4%
72,645
-5.7%
0.23%
-1.7%
Q3 2021$10,696,000
+20.6%
77,000
-15.7%
0.23%
+17.9%
Q2 2021$8,870,000
+46.3%
91,372
+3.0%
0.20%
+46.6%
Q1 2021$6,063,000
+1.9%
88,711
+27.8%
0.13%
+15.7%
Q4 2020$5,948,000
+10.2%
69,396
-16.4%
0.12%
-20.1%
Q3 2020$5,396,000
-11.1%
83,000
-0.0%
0.14%
-17.2%
Q2 2020$6,069,000
+36.4%
83,018
-36.5%
0.17%0.0%
Q1 2020$4,449,000
-14.0%
130,737
+37.6%
0.17%
+104.7%
Q4 2019$5,172,000
+7.8%
95,000
-17.4%
0.08%
-12.4%
Q3 2019$4,799,000
-16.4%
115,000
-12.2%
0.10%
-36.2%
Q2 2019$5,737,000
+1014.0%
131,000
+1210.0%
0.15%
+1069.2%
Q1 2019$515,000
+26.5%
10,000
-9.1%
0.01%
-23.5%
Q4 2018$407,000
-27.7%
11,000
-26.7%
0.02%
+13.3%
Q3 2018$563,000
+78.2%
15,000
+87.5%
0.02%
+87.5%
Q2 2018$316,0008,0000.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2021
NameSharesValueWeighting ↓
RP Management, LLC 2,111,111$144,294,00054.16%
Knoll Capital Management, LLC 856,844$58,565,00038.16%
ORACLE INVESTMENT MANAGEMENT INC 2,123,271$145,126,00021.73%
KINGDON CAPITAL MANAGEMENT, L.L.C. 860,261$58,799,0006.01%
ARS Investment Partners, LLC 561,442$38,375,0004.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$12,057,0003.19%
Eventide Asset Management 2,015,000$137,725,0002.04%
Avidity Partners Management LP 1,049,800$71,754,0001.98%
SILVERARC CAPITAL MANAGEMENT, LLC 50,089$3,424,0001.87%
Nicholas Investment Partners, LP 375,654$25,676,0001.79%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders